Back to Search
PAUL FRANKEL, PH.D.
PH.D.
Behavior Analyst
NPI: 1134407034Individual
Specialties, Licenses & Credentials
Behavior AnalystPrimary
Behavior Analyst
Code: 103K00000X
Research & Publications (20)
Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users.
PMID 18538358·Neuropharmacology·2008
8-other
Differential response of neurotensin to methamphetamine self-administration.
PMID 18991855·Ann N Y Acad Sci·2008
7-preclinical
Chondroitin sulphate-modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas-mediated pathway.
PMID 18704117·EMBO Rep·2008
4-observational
Brain levels of neuropeptides in human chronic methamphetamine users.
PMID 17688891·Neuropharmacology·2007
8-other
Mechanism of an exaggerated locomotor response to a low-dose challenge of methamphetamine.
PMID 17303233·Pharmacol Biochem Behav·2007
7-preclinical
A permutation test for a weighted Kaplan-Meier estimator with application to the nutritional prevention of cancer trial.
PMID 17150413·Contemp Clin Trials·2007
8-other
Differential neurotensin responses to low and high doses of methamphetamine in the terminal regions of striatal efferents.
PMID 16199030·Eur J Pharmacol·2005
4-observational
RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity.
PMID 15592429·EMBO J·2005
7-preclinical
m-Chlorophenylpiperazine (mCPP) modulates the discriminative stimulus effects of cocaine through actions at the 5-HT2C receptor.
PMID 14979792·Behav Neurosci·2004
7-preclinical
The hallucinogen d-lysergic acid diethylamide (d-LSD) induces the immediate-early gene c-Fos in rat forebrain.
PMID 12470860·Brain Res·2002
7-preclinical
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study.
PMID 19322566·Cancer Chemother Pharmacol·2009
3-trial
Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil.
PMID 19377795·Braz J Med Biol Res·2009
8-other
Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.
PMID 19307510·J Clin Oncol·2009
3-trial
Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma.
PMID 19096314·J Thorac Oncol·2009
3-trial
Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
PMID 19661346·Anticancer Res·2009
3-trial
Responses of limbic and extrapyramidal substance P systems to nicotine treatment.
PMID 18773198·Psychopharmacology (Berl)·2009
7-preclinical
PNPO deficiency: an under diagnosed inborn error of pyridoxine metabolism.
PMID 18485777·Mol Genet Metab·2008
7-preclinical
Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome.
PMID 18641005·Ann Oncol·2008
8-other
A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study.
PMID 18981013·Clin Cancer Res·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5220 S ULSTER ST, APT. 2302
GREENWOOD VILLAGE, CO 80111 - Phone
- (719) 237-0338
Quick Facts
- NPI
- 1134407034
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile